Medicine is undergoing one of its most significant transformations since the introduction of medical imaging and molecular diagnostics. Advances in genomics have shifted healthcare from treating diseases solely by their clinical manifestations toward understanding their biological and molecular causes. Genetic information now informs diagnosis, prognosis, treatment selection, prevention, reproductive planning and lifelong care.
Although individually uncommon, rare genetic diseases collectively represent a major group of chronic conditions. More than 300 million people worldwide are estimated to live with a rare disease, and most rare diseases have a genetic origin.1
Patients with inherited disorders may undergo years of consultations, investigations and referrals before the cause is identified—the diagnostic odyssey. This delay can postpone appropriate treatment and place substantial emotional and economic burdens on patients and families.2
Clinical genomics has changed this pathway. A 2024 evidence review of 71 studies and more than 13,000 patients found an unweighted mean diagnostic yield of 45% when genome sequencing was used first line, compared with 33% after prior genetic testing. Reported changes in management ranged from 24% to 100% among relevant cohorts.3
Medical Genetics therefore extends beyond identifying DNA variants. Clinicians integrate molecular findings with phenotype, medical and family history, imaging, laboratory results and current evidence to establish a clinically meaningful diagnosis and recommendations.
As precision medicine evolves, Medical Genetics connects genomic science with individualized care across neurology, oncology, cardiology, nephrology, pediatrics, obstetrics, reproductive medicine and many other disciplines.